Portal Therapeutics, Inc. Clinical Trial Pipeline: 1 Active Trials, 4 Changes This Month

1

Active Trials

1

Recruiting

4

Changes, 30 Days

What Changed in the Last 30 Days

Detected	Trial	Change
2026-07-30	NCT06971900 GATEWAY: A Phase 2a Study of PORT-77 in Adults With Erythropoietic Protoporphyria	overall status: Enrolling by Invitation → Completed
2026-07-30	NCT06971900 GATEWAY: A Phase 2a Study of PORT-77 in Adults With Erythropoietic Protoporphyria	Enrollment increased: 14 -> 28 participants
2026-07-30	NCT06971900 GATEWAY: A Phase 2a Study of PORT-77 in Adults With Erythropoietic Protoporphyria	date change Primary completion moved earlier: 2026-01-01 -> 2025-11-22
2026-07-30	NCT06971900 GATEWAY: A Phase 2a Study of PORT-77 in Adults With Erythropoietic Protoporphyria	date change Completion moved earlier: 2026-01 -> 2025-11-24

Active Trials by Phase

Not specified

1

Active Trials

NCT ID	Title	Condition	Status
Not specified
NCT07567131	Observational Study of Adults and Adolescents With Erythropoietic Protoporphyria (EPP)…	Erythropoietic Protoporphyria (EPP)	Recruiting

Get alerts when Portal Therapeutics, Inc.'s trials change

Status changes, date slips, and new filings — detected daily, delivered to your inbox.